Nicardipine use in cerebrovascular disease | 合法藥品大搜索

Read More

由 F Amenta 著作 · 2009 · 被引用 34 次 — Former studies did not demonstrate an advantage of nicardipine versus nimodipine in SAH. A more recent approach administering the drug intra- ... Read More

由 E Alborch 著作 · 1992 · 被引用 89 次 — Comparison of the anticonstrictor action of dihydropyridines (nimodipine and nicardipine) and Mg2+ in isolated human cerebral arteries. Eur J Pharmacol. Read More

由 Y Takata 著作 · 1986 · 被引用 17 次 — ... of orally administered nisoldipine (Bay k 5552) were compared with those of nifedipine, nimodipine and nicardipine in conscious renal hypertensive dogs. Read More

由 S Taylor 著作 · 2009 · 被引用 40 次 — Treatments for cerebral vasospasm, including triple-H therapy (therapeutic hypervolemia, hypertension, and hemodilution), nimodipine, balloon angioplasty, and ... Read More

由 M Grabowski 著作 · 1985 · 被引用 30 次 — Nifedipine and nimodipine: effect on blood pressure and regional cerebral blood flow in conscious normotensive and hypertensive rats. J Cardiovasc Pharmacol ... Read More

由 F Amenta 著作 · 2008 · 被引用 19 次 — SAH is a main cerebrovascular indication of CCBs. In this indication, CCBs prevent vasospasm and improve clinical outcomes. Nimodipine represents the CCB ... Read More

由 G Dabus 著作 · 2013 · 被引用 96 次 — Current accepted medical options include the oral nimodipine and 'triple-H' ... A subsequent randomized trial showed that low-dose nicardipine ... Read More

由 Y Liu 著作 · 2016 · 被引用 22 次 — Safety and effectiveness of nimodipine was recently shown in a ... of the patients four days after IA nicardipine treatment, and no drug-related ... Read More

Subarachnoid haemorrhage (SAH) is managed with CCBs to prevent vasospasm and improve clinical outcomes. Nimodipine is the CCB licensed for this ... Read More